NCT00113399 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 13
- units
- Participants
- groups
- description
- Radiation Therapy on weeks 1, 3, 5, and 7 1.5 Gy/fx, twice daily x 5 days, 40 fractions, for a total dose of 60 Gy; Chemotherapy (cisplatin/paclitaxel) on weeks 1, 3, 5, and 7 G-CSF on weeks 2, 4, 6, and 8. \[Data is reported for eligible patients with on-study information, which is 6 patients.\]
- id
- BG000
- title
- Re-irradiation Plus Concurrent Chemotherapy
- description
- Select from one of the three standard chemotherapy regimens: cisplatin/5-FU; cisplatin/paclitaxel; cisplatin/docetaxel. \[Data is reported for eligible patients with on-study information, which is 7 patients.\]
- id
- BG001
- title
- Chemotherapy Alone
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 44
- upper Limit
- 80
- value
- 56
- group Id
- BG001
- lower Limit
- 48
- upper Limit
- 68
- value
- 57
- group Id
- BG002
- lower Limit
- 44
- upper Limit
- 80
- value
- 57
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 11
- title
- Female
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 13
- units
- Participants
- groups
- description
- Radiation Therapy on weeks 1, 3, 5, and 7 1.5 Gy/fx, twice daily x 5 days, 40 fractions, for a total dose of 60 Gy; Chemotherapy (cisplatin/paclitaxel) on weeks 1, 3, 5, and 7 G-CSF on weeks 2, 4, 6, and 8. \[Data is reported for eligible patients with on-study information, which is 6 patients.\]
- id
- BG000
- title
- Re-irradiation Plus Concurrent Chemotherapy
- description
- Select from one of the three standard chemotherapy regimens: cisplatin/5-FU; cisplatin/paclitaxel; cisplatin/docetaxel. \[Data is reported for eligible patients with on-study information, which is 7 patients.\]
- id
- BG001
- title
- Chemotherapy Alone
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 44
- upper Limit
- 80
- value
- 56
- group Id
- BG001
- lower Limit
- 48
- upper Limit
- 68
- value
- 57
- group Id
- BG002
- lower Limit
- 44
- upper Limit
- 80
- value
- 57
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 11
- title
- Female
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle